ESC Premium Access

Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study

Congress Presentation

About the speaker

Doctor Tomoka Yonishi

Osaka University Graduate School of Medicine, Osaka (Japan)
0 follower

19 more presentations in this session

Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.

Speaker: Doctor V. Orshanskaya (Saint Petersburg, RU)


High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation for atrial fibrillation

Speaker: Doctor I. Morishima (Ogaki, JP)


Improvement in quality of life in patients that underwent catheter ablation for persistent atrial fibrillation.

Speaker: Doctor K. Nakajima (Tokyo, JP)


Association of coronary artery disease and revascularization with recurrence of atrial fibrillation after catheter ablation

Speaker: Doctor D. Hiraya (Ibaraki, JP)


Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument

Speaker: Doctor A. Bjorkenheim (Orebro, SE)


Access the full session

Poster Session 7 - Atrial fibrillation - Ablation

Speakers: Doctor T. Yonishi, Doctor V. Orshanskaya, Doctor I. Morishima, Doctor K. Nakajima, Doctor D. Hiraya...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb